-
Milestone Scientific Inc. (NYSE:MLSS)
Milestone Scientific Inc. (NYSE: MLSS) is a biomedical technology research and development company that patents, designs, and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic, and veterinary applications. Milestone’s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information, please visit our website: www.milestonescientific.com.
Jan Adriaan (Arjan) Haverhals
CEO and President of Milestone Scientific
Mr. Haverhals has served as Milestone Scientific’s President since September 2020 and as President and Chief Executive Officer of Milestone Scientific’s Dental Division, Wand Dental Inc., since June 2020. He brings more than 30 years of sales, marketing, product development, and international expansion experience within the medical device, pharmaceutical, and other industries. Prior to joining the Company, Mr. Haverhals was Senior Vice President of Sales at Xcentric Mold & Engineering, where he was instrumental in increasing sales productivity and efficiency for the company’s prototype injection molding services, which included leading healthcare company clients. Previously, at Straumann, LLC, a global leader in manufacturing medical and dental devices with over $1 billion in sales, he held a series of senior sales and marketing roles including Vice President of customer marketing & education, where he oversaw all product franchises and led the launch of more than 30 products in the North American market, resulting in double-digit growth. He also served as Senior Vice President for the Nordic Region at Straumann AB, Senior Vice President of Global Sales Digital Solutions, which included oversight of the strategic acquisition of Etkon; and served as Vice President of the Prosthetics Business Unit, where he introduced a new implant and prosthetics product line within a new market segment. He also served as Vice President of Global Marketing & Sales at Elkem AS, one of Norway’s largest industrial companies. Previously, Mr. Haverhals served as Executive Vice President of Marketing & Sales at Cresco Ti Systems Sàrl, a global dental implant company, where he was responsible for turning around and managing global sales, marketing, and international business, where he achieved over 100% return on investment for shareholders. Mr. Haverhals holds an MS in Pharmacy from the University of Leyden in the Netherlands.